FDA panel narrowly recommends authorization of first antiviral pill to treat COVID

Petition updateDemand FDA Approval for Emergency Use of Ivermectin for Covid 19 TreatmentFDA panel narrowly recommends authorization of first antiviral pill to treat COVID

Diana ZFair Lawn, NJ, United States

Nov 30, 2021

November 30, 2021 – A US Food and Drug Administration (FDA) advisory panel narrowly voted 13 to 10 today to recommend emergency use authorization for the antiviral pill molnupiravir from Merck and Ridgeback Biotherapeutics to treat COVID-19.

Support now

Sign this petition

Copy link

Facebook

Nextdoor

N.J. hospitals have potent COVID treatments. But some doctors aren’t aware

COVID-19 pill gets advisory panel approval